UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:UTI - US9139151040 - Common Stock
24.84 USD
-0.15 (-0.6%)
24.3402 USD
-0.5 (-2.01%)
UTI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 77 industry peers in the Diversified Consumer Services industry. UTI has an excellent profitability rating, but there are some minor concerns on its financial health. UTI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
UTI had positive earnings in the past year.
In the past year UTI had a positive cash flow from operations.
UTI had positive earnings in each of the past 5 years.
UTI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
UTI has a Return On Assets of 7.63%. This is in the better half of the industry: UTI outperforms 73.68% of its industry peers.
Looking at the Return On Equity, with a value of 19.21%, UTI belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
UTI's Return On Invested Capital of 10.46% is amongst the best of the industry. UTI outperforms 84.21% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UTI is in line with the industry average of 9.07%.
The 3 year average ROIC (7.27%) for UTI is below the current ROIC(10.46%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 19.21% | ||
| ROIC | 10.46% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
1.3 Margins
UTI has a better Profit Margin (7.54%) than 67.11% of its industry peers.
In the last couple of years the Profit Margin of UTI has grown nicely.
The Operating Margin of UTI (9.99%) is better than 65.79% of its industry peers.
UTI's Operating Margin has improved in the last couple of years.
UTI's Gross Margin of 49.68% is in line compared to the rest of the industry. UTI outperforms 52.63% of its industry peers.
UTI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 7.54% | ||
| GM | 49.68% |
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
2. Health
2.1 Basic Checks
UTI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for UTI has been increased compared to 1 year ago.
UTI has more shares outstanding than it did 5 years ago.
UTI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.17 indicates that UTI is not in any danger for bankruptcy at the moment.
The Altman-Z score of UTI (3.17) is better than 77.63% of its industry peers.
UTI has a debt to FCF ratio of 1.57. This is a very positive value and a sign of high solvency as it would only need 1.57 years to pay back of all of its debts.
UTI's Debt to FCF ratio of 1.57 is amongst the best of the industry. UTI outperforms 84.21% of its industry peers.
UTI has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
UTI has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.57 | ||
| Altman-Z | 3.17 |
ROIC/WACC1.23
WACC8.49%
2.3 Liquidity
A Current Ratio of 1.07 indicates that UTI should not have too much problems paying its short term obligations.
UTI has a Current ratio (1.07) which is in line with its industry peers.
A Quick Ratio of 1.07 indicates that UTI should not have too much problems paying its short term obligations.
UTI has a Quick ratio of 1.07. This is comparable to the rest of the industry: UTI outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
UTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.05%, which is quite impressive.
Measured over the past years, UTI shows a very strong growth in Earnings Per Share. The EPS has been growing by 65.96% on average per year.
Looking at the last year, UTI shows a quite strong growth in Revenue. The Revenue has grown by 14.05% in the last year.
Measured over the past years, UTI shows a very strong growth in Revenue. The Revenue has been growing by 22.67% on average per year.
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%0%
Revenue 1Y (TTM)14.05%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%13.28%
3.2 Future
Based on estimates for the next years, UTI will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.46% on average per year.
UTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.04% yearly.
EPS Next Y-29.91%
EPS Next 2Y-11.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y9.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.79, UTI is valued on the expensive side.
UTI's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of UTI to the average of the S&P500 Index (26.56), we can say UTI is valued inline with the index average.
A Price/Forward Earnings ratio of 31.09 indicates a quite expensive valuation of UTI.
The rest of the industry has a similar Price/Forward Earnings ratio as UTI.
The average S&P500 Price/Forward Earnings ratio is at 23.79. UTI is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.79 | ||
| Fwd PE | 31.09 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UTI is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, UTI is valued a bit cheaper than the industry average as 67.11% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.43 | ||
| EV/EBITDA | 10.55 |
4.3 Compensation for Growth
The decent profitability rating of UTI may justify a higher PE ratio.
A cheap valuation may be justified as UTI's earnings are expected to decrease with -11.46% in the coming years.
PEG (NY)N/A
PEG (5Y)0.33
EPS Next 2Y-11.46%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for UTI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
24.84
-0.15 (-0.6%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners94.95%
Inst Owner Change-1.21%
Ins Owners2.24%
Ins Owner Change5.47%
Market Cap1.35B
Revenue(TTM)835.62M
Net Income(TTM)63.02M
Analysts81.82
Price Target38.18 (53.7%)
Short Float %3.85%
Short Ratio2.77
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.09%
Min EPS beat(2)28.91%
Max EPS beat(2)69.26%
EPS beat(4)4
Avg EPS beat(4)73.64%
Min EPS beat(4)28.91%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)75.72%
EPS beat(12)10
Avg EPS beat(12)77.26%
EPS beat(16)14
Avg EPS beat(16)214.91%
Revenue beat(2)2
Avg Revenue beat(2)0.81%
Min Revenue beat(2)0.47%
Max Revenue beat(2)1.15%
Revenue beat(4)4
Avg Revenue beat(4)2.24%
Min Revenue beat(4)0.47%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.25%
Revenue beat(12)12
Avg Revenue beat(12)3.17%
Revenue beat(16)15
Avg Revenue beat(16)3.41%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-43.74%
EPS NQ rev (3m)-44.7%
EPS NY rev (1m)-14.26%
EPS NY rev (3m)-20.2%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)0.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.79 | ||
| Fwd PE | 31.09 | ||
| P/S | 1.62 | ||
| P/FCF | 24.43 | ||
| P/OCF | 13.89 | ||
| P/B | 4.12 | ||
| P/tB | 4.79 | ||
| EV/EBITDA | 10.55 |
EPS(TTM)1.14
EY4.59%
EPS(NY)0.8
Fwd EY3.22%
FCF(TTM)1.02
FCFY4.09%
OCF(TTM)1.79
OCFY7.2%
SpS15.35
BVpS6.03
TBVpS5.19
PEG (NY)N/A
PEG (5Y)0.33
Graham Number12.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 19.21% | ||
| ROCE | 13.99% | ||
| ROIC | 10.46% | ||
| ROICexc | 14.6% | ||
| ROICexgc | 16.35% | ||
| OM | 9.99% | ||
| PM (TTM) | 7.54% | ||
| GM | 49.68% | ||
| FCFM | 6.62% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
ROICexc(3y)10.21%
ROICexc(5y)8.25%
ROICexgc(3y)11.54%
ROICexgc(5y)9.21%
ROCE(3y)9.72%
ROCE(5y)7.88%
ROICexgc growth 3Y34.26%
ROICexgc growth 5YN/A
ROICexc growth 3Y33.76%
ROICexc growth 5YN/A
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
F-Score6
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.57 | ||
| Debt/EBITDA | 0.72 | ||
| Cap/Depr | 127.37% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 14.13 | ||
| Cash Conversion | 83.6% | ||
| Profit Quality | 87.84% | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | 3.17 |
F-Score6
WACC8.49%
ROIC/WACC1.23
Cap/Depr(3y)145.01%
Cap/Depr(5y)268.95%
Cap/Sales(3y)5.89%
Cap/Sales(5y)11.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%0%
EPS Next Y-29.91%
EPS Next 2Y-11.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.05%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%13.28%
Revenue Next Year9.06%
Revenue Next 2Y9.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.41%
EBIT growth 3Y47.33%
EBIT growth 5YN/A
EBIT Next Year47.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.14%
FCF growth 3YN/A
FCF growth 5Y99.08%
OCF growth 1Y13.31%
OCF growth 3Y28.35%
OCF growth 5Y54.57%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 5 / 10 to UTI.
Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?
ChartMill assigns a valuation rating of 3 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Overvalued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?
The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 21.79 and the Price/Book (PB) ratio is 4.12.
Can you provide the expected EPS growth for UTI stock?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to decline by -29.91% in the next year.